首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Bone Marrow Transplantation

Bone Marrow Transplantation杂志,由Springer Nature出版,于1997年创刊,Semimonthly,出版语言English,ISSN:0268-3369,E-ISSN:1476-5365。

投稿咨询
Bone Marrow Transplantation
Bone Marrow Transplantation
Bone Marrow Transplantation
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.1
CiteScore
7.6
期刊收录
SCI、SCIE

Bone Marrow Transplantation(中文译名:《骨髓移植》),ISSN:0268-3369,EISSN:1476-5365,是Springer Nature出版的国际性学术期刊,创刊于1997年,以Semimonthly形式稳定发行,2026年总发文量约145篇。该刊采用非OA开放访问,学科归属为医学 - 免疫学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.1,2025年期刊CiteScore为7.6,2025年期刊自引率约9.8%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Bone Marrow Transplantation长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期一般,3-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAGERMANY (FED REP GER)、Italy、Spain、England、France、Netherlands等为核心发文国家与地区;ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)SORBONNE UNIVERSITE、INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、UNICANCER、UNIVERSITY OF HAMBURG、UNIVERSITE DE PARIS、UNIVERSITY OF LONDON等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学 HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 TRANSPLANTATION 移植
2区 2区 2区 2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 TRANSPLANTATION 移植 ONCOLOGY 肿瘤学
2区 2区 2区 3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
TRANSPLANTATION 移植 HEMATOLOGY 血液学 IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
2区 3区 3区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 18 / 103

83

学科:IMMUNOLOGY SCIE Q2 51 / 183

72.4

学科:ONCOLOGY SCIE Q1 83 / 333

75.2

学科:TRANSPLANTATION SCIE Q1 4 / 30

88.3

学科:HEMATOLOGY SCIE Q1 19 / 103

82.04

学科:IMMUNOLOGY SCIE Q1 40 / 183

78.42

学科:ONCOLOGY SCIE Q1 76 / 333

77.33

学科:TRANSPLANTATION SCIE Q2 8 / 30

75

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 16 / 99

84.3

学科:IMMUNOLOGY SCIE Q1 41 / 183

77.9

学科:ONCOLOGY SCIE Q1 64 / 328

80.6

学科:TRANSPLANTATION SCIE Q1 4 / 31

88.7

学科:HEMATOLOGY SCIE Q1 20 / 100

80.5

学科:IMMUNOLOGY SCIE Q2 47 / 183

74.59

学科:ONCOLOGY SCIE Q2 83 / 328

74.85

学科:TRANSPLANTATION SCIE Q2 8 / 31

75.81


中国学者近期发文

1
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relaps

Author:Chen, Xiao-Tong; Shi, Ze-Chang; Wang, Yu; Zhang, Xiao-Hui; Chen, Huan; Chen, Yu-Hong; Wang, Feng-Rong; Sun, Yu-Qian; Yan, Chen-Hua; Lv, Meng; Mo, Xiao-Dong; Zhao, Xiao-Su; Huang, Xiao-Jun; Chang, Ying-Jun; Huo, Ming-Rui

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02859-4

2
Bringing the rare into sight: applications of haploidentical stem cell transplantation in the treatment of rare disease

Author:Ma, Xiao-Di; Xu, Zheng-Li; Huang, Xiao-Jun

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02839-8

3
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBM

Author:Kanellopoulos, Alexandros; Koster, Linda; de Lavallade, Hugues; Ortí, Guillermo; Francis, Sebastian; Passweg, Jakob; Apperley, Jane; Bethge, Wolfgang; Rabitsch, Werner; Clay, Jennifer; Forcade, Edouard; Hurst, Erin; Besley, Caroline; Kinsella, Francesca; Aljurf, Mahmoud; Huang, He; Ho, Aloysius; Hilgendorf, Inken; Choi, Goda; Ayuk, Francis; Grzegorz, Helbig; Stelljes, Matthias; Richardson, Deborah; Morozova, Elena; Prejzner, Witold; Zeiser, Robert; Armstrong, Christopher; Raj, Kavita; Drozd-Sokolowska, Joanna; Chalandon, Yves; McLornan, Donal P

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02862-9

4
Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcome

Author:Lin, Ming-Hao; Gao, Sheng-Nan; Huang, Xiao-Jun; Xu, Lan-Ping; Fu, Hai-Xia; Cheng, Yi-Fei; Han, Ting-Ting; Zhang, Yuan-Yuan; Mo, Xiao-Dong; Sun, Yu-Qian; Wang, Yu; Zhang, Xiao-Hui; Xu, Zheng-Li

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02855-8

5
Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphom

Author:Li, Jiaqi; Feng, Shanglong; Jia, Sixun; Zhang, Ying; Hua, Yuchen; Geng, Hongzhi; Chen, Jia; Kang, Liqing; Yu, Lei; Xu, Ting; Bao, Xiebing; Wu, Depei; Li, Caixia

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02858-5

6
Donor age ≥50 years combined with donor-CI ≥3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemi

Author:Wu, Ning; Kong, Jun; Lv, Meng; Mo, Xiao-Dong; Sun, Yu-Qian; Cheng, Yi-Fei; Xu, Lan-Ping; Zhang, Xiao-Hui; Huang, Xiao-Jun; Wang, Yu

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02844-x

7
Is sex chromosome loss a predictive marker for outcome after sex-mismatched allogeneic hematopoietic stem cell transplantation

Author:Gao, Lu; Li, Na; Feng, Lin; Zhang, Xiaohui; Xu, Lanping; Wang, Yu; Chang, Yingjun; Huang, Xiaojun; Lai, Yueyun

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02828-x

8
Differential clinical impact of HLA-DPA1∼DPB1 linkage mismatches in 14/14-matched unrelated donor HSCT: a multicenter retrospective study from CMDP revealing age- and disease-specific risk pattern

Author:Zhang, Tengteng; Bao, Xiaojing; Han, Ying; Yuan, Xiaoni; Li, Yang; Jiang, Xue; Yang, Tianjie; Du, Dan; He, Jun

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02835-y

9
The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVH

Author:Wu, Yibo; Liu, Lizhen; Chen, Yi; Lai, Xiaoyu; Chen, Yan; Lu, Ying; Yang, Luxin; Sun, Lan; He, Jiayi; Tong, Fenfang; Cao, Junjie; Li, Lin; Shi, Jimin; Zhao, Yanmin; Yuan, Xiaolin; Zhu, Panpan; Huang, He; Xu, Yajing; Luo, Yi

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02848-7

10
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBM

Author:Cesaro, Simone; Garonzi, Chiara; Tridello, Gloria; Verheggen, Inge; Liu, Daihong; Flynn, Catherine; Alahmari, Ali; Kaynar, Leylagul; Rabitsch, Werner; Uygun, Vedat; Chorao, Pedro; Hu, Jiong; Esquirol, Albert; Pinana, Jose Luis; Aljurf, Mahmoud; Wagner-Drouet, Eva; Lang, Peter; Martin-Sanchez, Guillermo; Ratip, Siret; Facchini, Luca; Nasilowska-Adamska, Barbara; Styczynski, Jan; Ram, Ron; Metafuni, Elisabetta; Tanase, Alina; Kalwak, Krzysztof; Serio, Bianca; Hashem, Hasan; Castagna, Luca; Vicent, Marta Gonzalez; Karakukcu, Musa; Halahleh, Khaled; Baltadakis, Ioannis; Benedetti, Edoardo; Mikulska, Malgorzata; De La Camara, Rafael; Averbuch, Dina

Journal: BONE MARROW TRANSPLANTATION. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41409-026-02832-1


在线咨询

Bone Marrow Transplantation

国际简称:BONE MARROW TRANSPL参考译名:骨髓移植

年发文量:145 CiteScore:7.6 是否预警:否 Gold OA文章占比:36.08% 研究类文章占比:90.34%

杂志社联系方式:NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Bone Marrow Transplantation